GenScript ProBio completes nearly $220 M Series C Round of financing in China

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...

January 27, 2023 | Friday | News
China-based startup ReLive Biotechnologies strengthens presence in regenerative therapy market

ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...

January 26, 2023 | Thursday | News
Hong Kong Science and Technology Parks Corp inks strategic collaboration with Roche

Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...

January 19, 2023 | Thursday | News
Chiome Bioscience terminates oncology agreement with Shanghai Henlius Biotech

Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...

January 23, 2023 | Monday | News
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer

Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...

January 19, 2023 | Thursday | News
Hong Kong to emerge as technology hub for microbiome industry in APAC region

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...

January 18, 2023 | Wednesday | News
Amcor expands healthcare platform in APAC with acquisition of China-based MDK

Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...

January 17, 2023 | Tuesday | News
China approves first and only therapy available for patients with EGFR Exon20 Insertion+ NSCLC

Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...

January 12, 2023 | Thursday | News
Hong Kong study identifies more cases of primary brain cancer in high-income countries

Primary brain cancer, though not a common malignancy, has a very poor survival rate compared to other types of cancer; m...

January 11, 2023 | Wednesday | News
Aurisco collaborates with Cytiva to build first Oligo FlexFactory in China

Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...

January 9, 2023 | Monday | News
WuXi Biologics, GSK ink $1.46 B deal for multiple novel bi- & multi-specific T cell engagers

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...

January 5, 2023 | Thursday | News
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board

China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company's Scientific Advisory...

January 16, 2023 | Monday | News
WuXi STA launches first continuous manufacturing line in China for oral solids

WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...

January 4, 2023 | Wednesday | News
Biocytogen and Hansoh Pharma announce antibody license agreement in China

Biocytogen Pharmaceuticals and Hansoh Pharmaceutical Group have announced an antibody collaboration, assignment and excl...

January 3, 2023 | Tuesday | News
Mission Bio, Abiosciences to co-develop bioinformatics for clinical research applications in China

US-based Mission Bio and Abiosciences have announced a new partnership to co-develop bioinformatics packages for transla...

December 30, 2022 | Friday | News
GeneQuantum and WuXi XDC to empower innovative bioconjugates development

China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...

December 28, 2022 | Wednesday | News
Nasal COVID-19 vaccine stored in NEST Disposable Intranasal Atomisation Device receives EUA in China

On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...

December 27, 2022 | Tuesday | News
China-based startup PVmed raises $14 M in series A funding

Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment startup...

December 23, 2022 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls